Patients with locally advanced head and neck cancer who received the immune checkpoint inhibitor pembrolizumab before, during and after standard-of-care surgery had longer event-free survival without ...

The team hopes this device will be used in high illicit drug activity places like clubs and festivals, and in addiction ...

Clario strengthens its leadership in digital endpoint data collection with the acquisition of WCG's eCOA business, enhancing support for neuroscience clinical trials.Acquisition expands Clario's ...

Biosimilars are gaining traction as competitors aim to capture market share from branded biologics such as Humira and ...

Fish oil is one of the most commonly used supplements. Fish oil lowers triglycerides, but its effect on other forms of ...

As President Trump tests what "due process" means under the law, the courts say his government must take steps to ensure fairness and safety of vulnerable individuals.

Only around 1 in 10 common non-surgical and non-invasive treatments for lower back pain is effective, suggests a pooled data ...

Momentum is building for PROTAC treatments that eliminate disease-causing proteins, including those responsible for difficult ...

In late April, Summit Therapeutics revealed interim OS data from HARMONi-2 for its PD-1/VEGF bispecific antibody, ivonescimab ...

Vertex's diversification efforts are most visible in the progress of its pain management portfolio. Read why I rate VRTX ...

The bispecific T-cell engager tarlatamab demonstrated favorable antitumor activity in a small cohort with small cell lung ...

A new analysis of existing literature in Annals of Internal Medicine suggests patients prescribed antivirals for nonsevere ...